Experience with percardiac interventions for multiple congenital heart diseases in children

Shijun Hu1, Yifeng Yang1, Yun Zhu1

  • 1Department of Cardiothoracic Surgery, The Second Xiangya Hospital, Central South University, Changsha, China.

Insights

Percardiac interventions offer a feasible approach for treating children with multiple congenital heart defects, showing satisfactory outcomes. Further research is needed to confirm long-term safety and effectiveness compared to traditional methods.

Area of Science:

  • Pediatric Cardiology
  • Interventional Cardiology
  • Congenital Heart Disease

Background:

  • Multiple congenital heart diseases (CHDs) in children often require complex management strategies.
  • Minimally invasive techniques are increasingly explored as alternatives to conventional open-heart surgery for CHDs.

Purpose of the Study:

  • To evaluate the feasibility and outcomes of percardiac interventions in pediatric patients with multiple CHDs.
  • To report initial experience with percardiac device closure and balloon valvuloplasty for various CHD combinations.

Main Methods:

  • A cohort of 64 pediatric patients with multiple CHDs underwent attempted percardiac interventions between April 2010 and December 2013.
  • Procedures included device closure for ventricular septal defects (VSDs), atrial septal defects (ASDs), patent ductus arteriosus (PDA), and balloon valvuloplasty for pulmonary stenosis (PS).
  • Interventions were performed via a mini-incision in the inferior sternum.

Main Results:

  • Successful occlusion was achieved in 92% (59/64) of patients; 8% (5/64) required conversion to open-heart surgery.
  • A total of 111 devices were implanted (average 1.88 devices/patient) with no severe complications reported.
  • Minor complications included incomplete right bundle branch block (8%), transient trivial valve regurgitation (2%), and pericardial effusion (2%).

Conclusions:

  • Percardiac intervention is a feasible and satisfactory treatment option for children with multiple CHDs.
  • Long-term follow-up and expanded experience are essential to fully assess the safety and efficacy of these minimally invasive procedures.
Abstract

Related Concept Videos

Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
583
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
746
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
801
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
786
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
511
Pericarditis IV: Nursing Management01:25

Pericarditis IV: Nursing Management

Pericarditis, an inflammation of the pericardium, necessitates diligent nursing management to ensure effective patient care and recovery. The initial step in managing pericarditis is a comprehensive patient medical assessment.The patient reports chest pain aggravated by breathing, coughing, and swallowing, which worsens when lying supine. The pain often improves when sitting up and leaning forward. Additional symptoms may include fever, malaise, and, in severe cases, signs of heart failure.
636